Late-Breaking Trials Spotlight New Venous Devices And Training

New Devices For Iliofemoral Disease

A subanalysis of the Vivid trial showed a hybrid iliac stent with an extension segment performed as expected in complex, often post-thrombotic disease, supporting use across the inguinal ligament when the overlap sits above it. A separate first-in-human study tested a catheter injecting tumescent anesthesia from inside the vein via a self-guided needle, cutting an uncomfortable step to near-zero median pain.

Ablation Without Tumescence And A New Valve Option

High-intensity focused ultrasound heats target tissue from outside the leg with no needle or incision, and a pivotal trial reported ablation rates above 90 percent through six months in appropriately sized veins. For deep venous reflux, one-year data on a bioprosthetic venous valve showed sustained quality-of-life and pain gains, healing most existing ulcers.

Faster Diagnosis And Standardized Training

An AI-guided compression ultrasound run by a non-expert matched standard duplex for sensitivity, letting roughly a third of ER patients skip a full vascular lab scan. Early data on perivenous dexamethasone suggested it limits collagen deposition after clot removal. A companion talk argued venous medicine lacks standardized training, pointing to certification as a path forward.